| Literature DB >> 31660258 |
Xuan Zhu1,2, Xing Niu3, Tao Li4, Chang Liu5, Lijie Chen6, Guang Tan7.
Abstract
OBJECTIVES: In recent years, with the development of biological materials, the types and clinical applications of stents have been increasing in pancreatic diseases. However, relevant problems are also constantly emerging. Our purpose was to summarize current hotspots and explore potential topics in the fields of the application of stent implantation in the treatment of pancreatic diseases for future scientific research.Entities:
Keywords: Bibliometrics; Hotspots; MeSH terms; Pancreatic diseases; Stents
Year: 2019 PMID: 31660258 PMCID: PMC6815650 DOI: 10.7717/peerj.7674
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
Figure 1The information of literature on the application of stents in pancreatic diseases.
(A) The growth of literature publications about the application of stents in pancreatic diseases from 1977 to 2018. (B) Geographic distribution of research outputs on the application of stents in pancreatic diseases. (C) Annual distribution of MeSH terms about the application of stents in pancreatic diseases.
The 29 top authors from the listed publications on the application of stents in pancreatic diseases (PubMed sourced until May 2018).
| No. | Author | Frequency | Percentage, % | Cumulative percentage, % |
|---|---|---|---|---|
| 1 | Baron TH | 84 | 2.0468 | 2.0468 |
| 2 | Kahaleh M | 81 | 1.9737 | 4.0205 |
| 3 | Isayama H | 65 | 1.5838 | 5.6043 |
| 4 | Itoi T | 58 | 1.4133 | 7.0175 |
| 5 | Nakai Y | 50 | 1.2183 | 8.2359 |
| 6 | Varadarajulu S | 49 | 1.194 | 9.4298 |
| 7 | Sherman S | 46 | 1.1209 | 10.5507 |
| 8 | Lehman GA | 41 | 0.999 | 11.5497 |
| 9 | Costamagna G | 39 | 0.9503 | 12.5 |
| 10 | Tada M | 39 | 0.9503 | 13.4503 |
| 11 | Bhasin DK | 38 | 0.9259 | 14.3762 |
| 12 | Koike K | 37 | 0.9016 | 15.2778 |
| 13 | Rana SS | 37 | 0.9016 | 16.1793 |
| 14 | Devière J | 36 | 0.8772 | 17.0565 |
| 15 | Freeman ML | 36 | 0.8772 | 17.9337 |
| 16 | Kogure H | 36 | 0.8772 | 18.8109 |
| 17 | Kozarek RA | 35 | 0.8528 | 19.6637 |
| 18 | Hirano K | 32 | 0.7797 | 20.4435 |
| 19 | Ito K | 31 | 0.7554 | 21.1988 |
| 20 | Wilcox CM | 31 | 0.7554 | 21.9542 |
| 21 | Sasahira N | 31 | 0.7554 | 22.7096 |
| 22 | Sasaki T | 30 | 0.731 | 23.4405 |
| 23 | Huibregtse K | 27 | 0.6579 | 24.0984 |
| 24 | Kim MH | 27 | 0.6579 | 24.7563 |
| 25 | Yamamoto N | 27 | 0.6579 | 25.4142 |
| 26 | Khashab MA | 26 | 0.6335 | 26.0478 |
| 27 | Lee JH | 26 | 0.6335 | 26.6813 |
| 28 | Gupta R | 26 | 0.6335 | 27.3148 |
| 29 | Adler DG | 26 | 0.6335 | 27.9483 |
| Total | 1,147 |
Notes.
Proportion of the frequency among 1,147 times’ appearance.
Most active journals on the topic of the application of stents in pancreatic diseases (PubMed sourced until May 2018).
| No. | Top journals | Publications n (%) |
|---|---|---|
| 1 | Gastrointestinal endoscopy | 517 (12.55) |
| 2 | Endoscopy | 339 (8.23) |
| 3 | World journal of gastroenterology | 107 (2.60) |
| 4 | Surgical endoscopy | 101 (2.45) |
| 5 | Digestive endoscopy: official journal of the Japan Gastroenterological Endoscopy Society | 87 (2.11) |
| 6 | The American journal of gastroenterology | 76 (1.85) |
| 7 | Hepato-gastroenterology | 76 (1.85) |
| 8 | Cardiovascular and interventional radiology | 61 (1.48) |
| 9 | Gastrointestinal endoscopy clinics of North America | 61 (1.48) |
| 10 | Digestive diseases and sciences | 59 (1.43) |
| 11 | JOP: Journal of the pancreas | 51 (1.24) |
| 12 | Journal of gastroenterology and hepatology | 51 (1.24) |
| 13 | Journal of vascular and interventional radiology: JVIR | 48 (1.17) |
| 14 | Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract | 45 (1.09) |
| 15 | Journal of clinical gastroenterology | 45 (1.09) |
| 16 | Pancreas | 44 (1.07) |
| 17 | Pancreatology: official journal of the International Association of Pancreatology (IAP) ... [et al. ] | 40 (0.97) |
| 18 | World journal of gastrointestinal endoscopy | 35 (0.85) |
| 19 | Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association | 33 (0.80) |
| 20 | Gut | 33 (0.80) |
| 21 | Endoscopic ultrasound | 32 (0.78) |
| 22 | HPB: the official journal of the International Hepato Pancreato Biliary Association | 30 (0.73) |
| 23 | Gan to kagaku ryoho. Cancer & chemotherapy | 29 (0.70) |
| 24 | Journal of hepato-biliary-pancreatic sciences | 29 (0.70) |
| 25 | Annals of surgery | 27 (0.66) |
| Total | 2056(49.92) |
83 High-frequent major MeSH terms from the listed publications on the application of stents in pancreatic diseases.
| No. | Major MeSH | Frequency, n | Percentage, % | Cumulative percentage, % |
|---|---|---|---|---|
| 1 | Stents | 2238 | 3.8488 | 13.9489 |
| 2 | Treatment Outcome | 1038 | 1.7851 | 27.731 |
| 3 | Retrospective Studies | 758 | 1.3036 | 30.3725 |
| 4 | Cholangiopancreatography, Endoscopic Retrograde | 677 | 1.1643 | 31.5368 |
| 5 | Pancreatic Neoplasms/complications | 544 | 0.9355 | 32.4723 |
| 6 | Follow-Up Studies | 472 | 0.8117 | 33.284 |
| 7 | Drainage/methods | 452 | 0.7773 | 34.0614 |
| 8 | Pancreatic Neoplasms/surgery | 449 | 0.7722 | 34.8335 |
| 9 | Stents/adverse effects | 401 | 0.6896 | 35.5231 |
| 10 | Cholestasis/etiology | 379 | 0.6518 | 36.1749 |
| 11 | Tomography, X-ray Computed | 371 | 0.638 | 36.813 |
| 12 | Pancreatitis/etiology | 338 | 0.5813 | 37.3942 |
| 13 | Cholangiopancreatography, Endoscopic Retrograde/adverse effects | 335 | 0.5761 | 37.9704 |
| 14 | Cholangiopancreatography, Endoscopic Retrograde/methods | 314 | 0.54 | 38.5104 |
| 15 | Prospective Studies | 297 | 0.5108 | 39.0211 |
| 16 | Pancreatic Ducts/surgery | 295 | 0.5073 | 39.5284 |
| 17 | Time Factors | 289 | 0.497 | 40.0255 |
| 18 | Drainage | 281 | 0.4832 | 40.5087 |
| 19 | Palliative Care | 270 | 0.4643 | 40.973 |
| 20 | Endosonography | 254 | 0.4368 | 41.4099 |
| 21 | Cholestasis/therapy | 250 | 0.4299 | 42.2766 |
| 22 | Risk Factors | 244 | 0.4196 | 42.6962 |
| 23 | Pancreatic Neoplasms/pathology | 238 | 0.4093 | 43.1055 |
| 24 | Cholestasis/surgery | 226 | 0.3887 | 43.4942 |
| 25 | Chronic Disease | 198 | 0.3405 | 43.8347 |
| 26 | Drainage/instrumentation | 195 | 0.3354 | 44.17 |
| 27 | Metals | 185 | 0.3182 | 44.4882 |
| 28 | Pancreatic Ducts | 184 | 0.3164 | 44.8046 |
| 29 | Sphincterotomy, Endoscopic | 182 | 0.313 | 45.1176 |
| 30 | Pancreatic Pseudocyst/surgery | 182 | 0.313 | 45.4306 |
| 31 | Recurrence | 179 | 0.3078 | 45.7385 |
| 32 | Pancreatitis/complications | 177 | 0.3044 | 46.0429 |
| 33 | Pancreatitis/surgery | 176 | 0.3027 | 46.3455 |
| 34 | Pancreatic Neoplasms/therapy | 169 | 0.2906 | 46.6362 |
| 35 | Jaundice, Obstructive/etiology | 164 | 0.282 | 46.9182 |
| 36 | Prosthesis Design | 164 | 0.282 | 47.2002 |
| 37 | Pancreatitis/prevention & control | 164 | 0.282 | 47.4823 |
| 38 | Acute Disease | 163 | 0.2803 | 47.7626 |
| 39 | Equipment Design | 162 | 0.2786 | 48.0412 |
| 40 | Palliative Care/methods | 158 | 0.2717 | 48.3129 |
| 41 | Bile Duct Neoplasms/complications | 157 | 0.27 | 48.5829 |
| 42 | Pancreatitis/therapy | 151 | 0.2597 | 49.1057 |
| 43 | Endoscopy, Digestive System | 150 | 0.258 | 49.3637 |
| 44 | Endoscopy, Digestive System/methods | 146 | 0.2511 | 49.6148 |
| 45 | Survival Rate | 144 | 0.2476 | 49.8624 |
| 46 | Pancreas/surgery | 143 | 0.2459 | 50.1083 |
| 47 | Pancreatic Diseases/surgery | 132 | 0.227 | 50.5692 |
| 48 | Cholangiopancreatography, Endoscopic Retrograde/instrumentation | 131 | 0.2253 | 50.7945 |
| 49 | Pancreaticoduodenectomy | 130 | 0.2236 | 51.0181 |
| 50 | Pancreatic Neoplasms/mortality | 128 | 0.2201 | 51.2382 |
| 51 | Pancreatic Fistula/etiology | 127 | 0.2184 | 51.4566 |
| 52 | Postoperative Complications | 127 | 0.2184 | 51.675 |
| 53 | Endosonography/methods | 125 | 0.215 | 51.89 |
| 54 | Prognosis | 125 | 0.215 | 52.105 |
| 55 | Pancreatic Ducts/pathology | 122 | 0.2098 | 52.3148 |
| 56 | Pancreatic Neoplasms/diagnosis | 121 | 0.2081 | 52.5229 |
| 57 | Endoscopy | 119 | 0.2047 | 52.7275 |
| 58 | Cholestasis, Extrahepatic/etiology | 117 | 0.2012 | 52.9287 |
| 59 | Pancreatic Ducts/diagnostic imaging | 116 | 0.1995 | 53.1282 |
| 60 | Pancreaticoduodenectomy/adverse effects | 115 | 0.1978 | 53.326 |
| 61 | Sphincterotomy, Endoscopic/methods | 114 | 0.1961 | 53.522 |
| 62 | Constriction, Pathologic/therapy | 114 | 0.1961 | 53.7181 |
| 63 | Pancreatic Pseudocyst/diagnostic imaging | 113 | 0.1943 | 53.9124 |
| 64 | Constriction, Pathologic/etiology | 113 | 0.1943 | 54.1068 |
| 65 | Risk Assessment | 113 | 0.1943 | 54.3011 |
| 66 | Ultrasonography, Interventional | 112 | 0.1926 | 54.4937 |
| 67 | Postoperative Complications/etiology | 112 | 0.1926 | 54.6863 |
| 68 | Pancreatic Diseases/therapy | 112 | 0.1926 | 54.8789 |
| 69 | Radiography | 110 | 0.1892 | 55.0681 |
| 70 | Pancreatic Pseudocyst/therapy | 110 | 0.1892 | 55.2573 |
| 71 | Ampulla of Vater/surgery | 110 | 0.1892 | 55.4464 |
| 72 | Pancreatic Neoplasms/diagnostic imaging | 109 | 0.1875 | 55.6339 |
| 73 | Ampulla of Vater | 109 | 0.1875 | 55.8214 |
| 74 | Jaundice, Obstructive/surgery | 108 | 0.1857 | 56.0071 |
| 75 | Common Bile Duct Neoplasms/surgery | 107 | 0.184 | 56.1911 |
| 76 | Adenocarcinoma/surgery | 106 | 0.1823 | 56.3734 |
| 77 | Pancreatitis/diagnosis | 101 | 0.1737 | 56.5471 |
| 78 | Constriction, Pathologic | 101 | 0.1737 | 56.7208 |
| 79 | Diagnosis, Differential | 97 | 0.1668 | 56.8876 |
| 80 | Postoperative Complications/epidemiology | 95 | 0.1634 | 57.051 |
| 81 | Constriction, Pathologic/surgery | 94 | 0.1617 | 57.2126 |
| 82 | Cholestasis, Extrahepatic/therapy | 92 | 0.1582 | 57.3708 |
| 83 | Pancreatitis, Chronic/complications | 92 | 0.1582 | 57.5291 |
Notes.
MeSH: Medical Subject Headings
Proportion of the frequency among 19282 times’ appearance.
Figure 2A mountain visualization biclustering of 83 high-frequent major MeSH terms and papers on the application of stents in pancreatic diseases.
Figure 3A visualized matrix biclustering of highly frequent major MeSH terms and PubMed Unique Identifiers (PMIDs) of articles on the application of stents in pancreatic diseases.
The centrality and density of the 8 clusters.
| Cluster | Intra-class link averages | Centrality-X | Intra-class link averages | Density-Y |
|---|---|---|---|---|
| 0 | 8.446666667 | −4.62712 | 33.16071429 | −22.7996 |
| 1 | 15.29292929 | 2.219142 | 75.47272727 | 19.51241 |
| 2 | 9.875586854 | −3.1982 | 31.62878788 | −24.3315 |
| 3 | 24.98033126 | 11.90654 | 98.67032967 | 42.71001 |
| 4 | 12.63963964 | −0.43415 | 68.26388889 | 12.30357 |
| 5 | 13.39589041 | 0.322103 | 55.3 | −0.66032 |
| 6 | 8.673972603 | −4.39982 | 27.58888889 | −28.3714 |
| 7 | 11.28528529 | −1.7885 | 57.59722222 | 1.636902 |
| total | 13.07378775 | 55.96031989 |
The cluster analysis of 8 clusters.
| Cluster | Number of MeSH terms | Cluster analysis |
|---|---|---|
| 0 | 23,34,56,58,69,72,79,82 | Stents placement in pancreatic neoplasms |
| 1 | 5,9,10,19,21,24,27,36,39,40,41 | The complications of stents placement in bile duct neoplasms and pancreatic neoplasms |
| 2 | 8,35,45,49,50,52,54,71,73,74,75,76 | postoperative complications after stent placement such as pancreaticoduodenectomy |
| 3 | 1,2,3,6,11,15,17,18,46,47,51,60,67,80 | Stents for the prevention of pancreatic fistula following pancreaticoduodenectomy |
| 4 | 12,13,14,22,28,37,48,61,65 |
|
| 5 | 4,25,29,31,32,33,38,42,57,77 | The diagnosis, surgery and therapy of pancreatitis |
| 6 | 16,43,55,59,62,64,68,78,81,83 | Pancreatic ducts changes in patients with chronic pancreatitis |
| 7 | 7,21,26,30,44,53,63,66,70 | Stent placement in endoscopic pancreatic pseudocyst drainage |
Notes.
Represents the serial number of high-frequency MeSH terms.
Figure 4Strategic diagram for the application of stents in pancreatic diseases.
(A) The meaning of strategic diagram. (B) The strategic diagram of the 8 clusters for the application of stents in pancreatic diseases.
Figure 5Social network analysis.
(A) The top 29 author relationship network. The size and location of nodes represent the centrality of an author in the social network. (B) The network of high-frequent major MeSH terms. Nodes suggest high-frequent major MeSH terms. The size and location of nodes represent the centrality of a MeSH term in the network structure map. Links stand for the connection between MeSH terms, and the number or thickness of the lines stands for the co-occurrence frequency of high-frequent major MeSH terms.